Understanding the Potential Role of ERLIN1 in Diseases (G10613)

Target Name: ERLIN1

NCBI ID: G10613

ERLIN1

Understanding the Potential Role of ERLIN1 in Diseases

ERLIN1 (ERLIN1 variant 2) is a gene that encodes for a protein known as ERLIN1. ERLIN1 is a member of the EML family of proteins, which are involved in the regulation of RNA processing and homeostasis. ERLIN1 has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

ERLIN1 and its function

ERLIN1 is a 21-kDa protein that is expressed in various tissues and cells of the body. It is involved in the regulation of RNA processing, including the addition of end-modifying molecules and the removal of introns from RNA. ERLIN1 is also involved in the regulation of post-transcriptional modifications, such as RNA-binding protein (RBP) interactions and RNA stability.

In addition to its role in RNA processing, ERLIN1 is also involved in the regulation of cellular processes that are crucial for cell survival, such as cell growth, apoptosis, and autophagy. It has been shown to play a role in the regulation of cell cycle progression, and is involved in the development and progression of various cancers.

ERLIN1 as a drug target

ERLIN1 has been identified as a potential drug target due to its involvement in various cellular processes that are crucial for human health. One of the main reasons for its potential as a drug target is its involvement in the regulation of cell cycle progression, which is a key factor in the development and progression of cancer.

In addition to its role in cell cycle progression, ERLIN1 is also involved in the regulation of apoptosis, which is a crucial process for the elimination of damaged or dysfunctional cells. ERLIN1 has been shown to play a role in the regulation of apoptosis in various cellular contexts, including the regulation of neurodegenerative diseases.

ERLIN1 has also been shown to be involved in the regulation of cellular signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. Therefore, inhibition of the PI3K/Akt signaling pathway by ERLIN1 could be a potential strategy for the treatment of neurodegenerative diseases.

ERLIN1 as a biomarker

ERLIN1 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. One of the main reasons for its potential as a biomarker is its involvement in the regulation of cellular processes that are crucial for human health.

In addition to its role in the regulation of cellular processes, ERLIN1 is also involved in the regulation of RNA processing, which is a crucial step in the development of most proteins. Therefore, changes in the level of ERLIN1 expression or activity could be an indication of the development of certain diseases.

ERLIN1 has been shown to be involved in the regulation of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, ERLIN1 has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its role in neurodegenerative diseases, ERLIN1 has also been shown to be involved in the regulation of cancer. For example, ERLIN1 has been shown to play a role in the regulation of the development and progression of various cancers, including breast cancer and colorectal cancer.

Conclusion

In conclusion, ERLIN1 is a gene that encodes for a protein involved in the regulation of RNA processing and homeostasis. ERLIN1 has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of ERLIN1 in these diseases and to develop effective treatments.

Protein Name: ER Lipid Raft Associated 1

Functions: Component of the ERLIN1/ERLIN2 complex which mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs). Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway. Binds cholesterol and may promote ER retention of the SCAP-SREBF complex (PubMed:24217618)

The "ERLIN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ERLIN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets